Hallmarks of senescence in carcinogenesis and cancer therapy
The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a signal transduction program leading to irreversible cell cycle arrest. This growth arrest can be triggered by many different mechanisms including recognition by cellular sensors of DNA double-strand breaks leading to the activation of cell cycle checkpoint responses and recruitment of DNA repair foci. Senescence is initiated by the shortening of telomeres (replicative senescence) or by other endogenous and exogenous acute and chronic stress signals (STASIS: stress or aberrant signaling-induced senescence). The process of carcinogenesis involves a series of changes that allow tumor cells to bypass the senescence program. Nevertheless, tumor cells retain the capacity to undergo senescence. Treatment of tumor cells with many conventional anticancer therapies activates DNA damage signaling pathways, which induce apoptosis in some cells and senescence in others. Overexpression of tumor suppressors or inhibition of oncogenes can also induce rapid senescence in tumor cells. Senescent cells, while not dividing, remain metabolically active and produce many secreted factors, some of which stimulate and others inhibit the growth of tumors. The emerging knowledge about the pathways that lead to senescence and determine the pattern of gene expression in senescent cells may lead to more effective treatments for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, some tumor cells retain the ability to senesce in response to DNA-damaging chemotherapy or p53 reactivation; in mice, this response arrests tumor progression [ 20 – 22 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [20]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“When some telomeres are short, cells undergo a growth arrest called replicative senescence (Hayflick and Moorhead, 1961; Harley et al., 1990; Shay and Wright, 2001).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Also, as in the case of replicative senescence, these cells remain metabolically and synthetically active and show characteristic changes in morphology (Dimri et al., 1995; Serrano et al., 1997; Drayton and Peters, 2002).”
BackgroundSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“Telomerase activity is present in almost all human tumors but not in adjacent normal cells (Kim et al., 1994; Shay and Bacchetti, 1997).”
BackgroundSelf-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 3×
“When some telomeres are short, cells undergo a growth arrest called replicative senescence (Hayflick and Moorhead, 1961; Harley et al., 1990; Shay and Wright, 2001).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“Also, as in the case of replicative senescence, these cells remain metabolically and synthetically active and show characteristic changes in morphology (Dimri et al., 1995; Serrano et al., 1997; Drayton and Peters, 2002).”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Self-citationIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase is a eukaryotic ribonucleoprotein complex (Greider and Blackburn, 1985; Morin, 1989; Blackburn, 1992; Lingner et al., 1997; Nakamura et al., 1997; Weinrich et al., 1997; Nugent and Lundblad, 1998; Bryan and Cech, 1999) that helps to stabilize telomere length in human stem cells,…”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 2×
“It has recently been shown that DNA damage signals from telomeres induce typical DNA damage foci containing factors such as g-H2AX, MRE11, NBS1, MDC1, 53BP1, RAD50, and BRCA1 at M1 senescence (di Fagagna et al., 2003).”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Self-citationMammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 1×
“…repetitive TTAGGG tracts followed by a single-strand overhang on the 30 G-rich strand that ends in a lariat-like structure called a t-loop (Blackburn and Gall, 1978; Cooke and Smith, 1986; Moyzis et al., 1988; Chong et al., 1995; Broccoli et al., 1997; Griffith et al., 1999; Stansel et al., 2001).”
BackgroundRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“A recent concept is that p16 may enable pRB to establish a chromatin state that once established is irreversible and no longer dependent on the presence of p16 or pRB (Narita et al., 2003 and unpublished observations).”
BackgroundTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256 · cited 1×
“Telomerase is a eukaryotic ribonucleoprotein complex (Greider and Blackburn, 1985; Morin, 1989; Blackburn, 1992; Lingner et al., 1997; Nakamura et al., 1997; Weinrich et al., 1997; Nugent and Lundblad, 1998; Bryan and Cech, 1999) that helps to stabilize telomere length in human stem cells,…”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“Telomerase functions by adding TTAGGG repeats onto the telomeres using its intrinsic RNA as a template for reverse transcription (Feng et al., 1995).”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · cited 2×
“Late-generation telomerase-deficient mice show severe proliferative defects leading to immune dysfunction and failure to reproduce (Blasco et al., 1997; Lee et al., 1998; Chin et al., 1999; Rudolph et al., 1999).”
BackgroundThe multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
A highly conserved repetitive DNA sequence,(TTAGGG) n, present at the telomeres of human chromosomes
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 1,820 · cited 1×
“…repetitive TTAGGG tracts followed by a single-strand overhang on the 30 G-rich strand that ends in a lariat-like structure called a t-loop (Blackburn and Gall, 1978; Cooke and Smith, 1986; Moyzis et al., 1988; Chong et al., 1995; Broccoli et al., 1997; Griffith et al., 1999; Stansel et al., 2001).”
BackgroundKirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774 · cited 1×
“The idea called ‘antagonistic pleiotropy’ in the simplest context would argue that what is good for an individual early in life could be bad or lead to undesirable consequences when old (Kirkwood, 1988; Kirkwood and Austad, 2000).”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · cited 3×
“The paracrine effects of p21 induction mimic the tumor-promoting activities that are present not only in normal senescent fibroblasts (Krtolica et al., 2001) but also in tumor-associated stromal fibroblasts (Elenbaas and Weinberg, 2001).”
BackgroundTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709 · cited 1×
“…and form a complex providing a protective cap over the ends of the chromosomes that protects chromosome termini from degradation, recombination, and end-joining reactions (van Steensel et al., 1998; Kim et al., 1999; Li et al., 2000; Bailey et al., 2001; Baumann and Cech, 2001; de Lange, 2002).”
BackgroundTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Owing to the incomplete replication of lagging strand DNA synthesis (Watson, 1972), telomeres progressively shorten in all somatic cells with each cell division (Olovnikov, 1973; de Lange et al., 1990; Hastie et al., 1990; Harley et al., 1990; Lindsey et al., 1991).”
BackgroundWATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495 · cited 1×
“Telomerase is a eukaryotic ribonucleoprotein complex (Greider and Blackburn, 1985; Morin, 1989; Blackburn, 1992; Lingner et al., 1997; Nakamura et al., 1997; Weinrich et al., 1997; Nugent and Lundblad, 1998; Bryan and Cech, 1999) that helps to stabilize telomere length in human stem cells,…”
BackgroundAtm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,458 · cited 1×
“This is in contrast to MEFs from KU80 / , ATM / , or BRCA2 mutant mice, which are deficient in certain DNA damage responses (Barlow et al., 1996; Nussenzweig et al., 1996; Xu and Baltimore, 1996).”
ResultReversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Telomere states and cell fates
Blackburn, E. H. (2000) · Nature · doi:10.1038/35040500 · Cited by 1,377 · cited 1×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundCloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351 · cited 1×
“…which produces multiple effects on gene expression, including transcriptional activation of p21Waf1/Cip1, a pleiotropic inhibitor of different cyclin/cyclin-dependent kinases (CDKs) (Dotto, 2000). p21 induction causes cell cycle arrest in senescent cells (Noda et al., 1994; Alcorta et al., 1996).”
BackgroundLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 1×
“Late-generation telomerase-deficient mice show severe proliferative defects leading to immune dysfunction and failure to reproduce (Blasco et al., 1997; Lee et al., 1998; Chin et al., 1999; Rudolph et al., 1999).”
BackgroundBryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R. (1997) · Nature Medicine · doi:10.1038/nm1197-1271 · Cited by 1,292
Telomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“Late-generation telomerase-deficient mice show severe proliferative defects leading to immune dysfunction and failure to reproduce (Blasco et al., 1997; Lee et al., 1998; Chin et al., 1999; Rudolph et al., 1999).”
BackgroundReverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · cited 1×
“Telomerase is a eukaryotic ribonucleoprotein complex (Greider and Blackburn, 1985; Morin, 1989; Blackburn, 1992; Lingner et al., 1997; Nakamura et al., 1997; Weinrich et al., 1997; Nugent and Lundblad, 1998; Bryan and Cech, 1999) that helps to stabilize telomere length in human stem cells,…”
BackgroundTelomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085 · cited 2×
“More direct evidence that p53 may act as a sensor for short telomeres came from the study of Terc / mice crossed to p53þ / mice (Artandi et al., 2000).”
BackgroundResultA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · cited 3×
“…(Roninson, 2002a) as demonstrated in nude mouse xenografts of human tumor cell lines (Roninson et al., 2001; Elmore et al., 2002), in carcinogen-induced rat mammary tumors (Christov et al., 2003), and in murine Oncogene Em-myc lymphoma, a transgenic model of B-cell lymphoma (Schmitt et al., 2002).”
BackgroundInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Pot1, the Putative Telomere End-Binding Protein in Fission Yeast and Humans
Baumann, P., & Cech, T. R. (2001) · Science · doi:10.1126/science.1060036 · Cited by 1,028 · cited 1×
“…and form a complex providing a protective cap over the ends of the chromosomes that protects chromosome termini from degradation, recombination, and end-joining reactions (van Steensel et al., 1998; Kim et al., 1999; Li et al., 2000; Bailey et al., 2001; Baumann and Cech, 2001; de Lange, 2002).”
BackgroundBlackburn, E. H., & Gall, J. G. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90294-2 · Cited by 1,023 · cited 1×
“…duplex repetitive TTAGGG tracts followed by a single-strand overhang on the 30 G-rich strand that ends in a lariat-like structure called a t-loop (Blackburn and Gall, 1978; Cooke and Smith, 1986; Moyzis et al., 1988; Chong et al., 1995; Broccoli et al., 1997; Griffith et al., 1999; Stansel et…”
BackgroundAlcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“Late-generation telomerase-deficient mice show severe proliferative defects leading to immune dysfunction and failure to reproduce (Blasco et al., 1997; Lee et al., 1998; Chin et al., 1999; Rudolph et al., 1999).”
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951 · cited 4×
“…though there is no evidence for a counting mechanism in the growth arrest of cultured mouse cells, similar to wild-type mouse cells, telomerase-negative MEFs stop dividing after only 10–15 doublings, long before significant telomere erosion occurs (Sherr and DePinho, 2000; Wright and Shay, 2000).”
BackgroundInfluentialProtection of mammalian telomeres
de Lange, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205080 · Cited by 942 · cited 2×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundAn alternative pathway for yeast telomere maintenance rescues est1− senescence
Lundblad, V., & Blackburn, E. H. (1993) · Cell · doi:10.1016/0092-8674(93)90234-h · Cited by 942 · cited 1×
“In Saccharomyces cerevisiae, there are two homologous recombination pathways involved in ALT, RAD50, and RAD51 (Lundblad and Blackburn, 1993; Chen et al., 2001).”
BackgroundHuman telomeres contain two distinct Myb–related proteins, TRF1 and TRF2
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997) · Nature Genetics · doi:10.1038/ng1097-231 · Cited by 926
Makarov, V. L., Hirose, Y., & Langmore, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)81908-x · Cited by 922 · cited 1×
“…is altered, or telomere proteins are mutated or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et…”
BackgroundHuman Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
Self-citationTelomere maintenance by recombination in human cells
Dunham, M. A., Neumann, A. A., Fasching, C. L., & Reddel, R. R. (2000) · Nature Genetics · doi:10.1038/82586 · Cited by 879
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
Senescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796 · cited 1×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundWeinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 766
Self-citationA role for both RB and p53 in the regulation of human cellular senescence*1
SHAY, J. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90453-2 · Cited by 757 · cited 1×
“In cells that have bypassed telomere-based replicative senescence as a result of loss of p53 function, an outstanding question has been how cells deal with the shortest telomeres during the extended lifespan period before cells enter crisis (Shay et al., 1991; Wright and Shay, 1992, 1996).”
BackgroundSelf-citationSherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745 · cited 3×
“…though there is no evidence for a counting mechanism in the growth arrest of cultured mouse cells, similar to wild-type mouse cells, telomerase-negative MEFs stop dividing after only 10–15 doublings, long before significant telomere erosion occurs (Sherr and DePinho, 2000; Wright and Shay, 2000).”
BackgroundHart, R. W., & Setlow, R. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.6.2169 · Cited by 739 · cited 1×
“One possibility is that mouse and rat cells repair DNA damage much less efficiently than human cells (Hart and Setlow, 1974) and are thus much more sensitive to a variety of agents that produce oxidative stress (Kapahi et al., 1999).”
BackgroundIf not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725 · cited 3×
“In particular, p16-deficient tumor cell lines, such as HT1080 and HCT116, show a strong senescence response both in vitro and in vivo (Chang et al., 1999a; Roninson et al., 2001), and 13% of the SA-b-gal-positive breast cancers did not stain for p16 (te Poele et al., 2002).”
BackgroundSelf-citationTumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694 · cited 1×
“…repetitive TTAGGG tracts followed by a single-strand overhang on the 30 G-rich strand that ends in a lariat-like structure called a t-loop (Blackburn and Gall, 1978; Cooke and Smith, 1986; Moyzis et al., 1988; Chong et al., 1995; Broccoli et al., 1997; Griffith et al., 1999; Stansel et al., 2001).”
BackgroundRequirement for Ku80 in growth and immunoglobulin V(D)J recombination
Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M. C., & Li, G. C. (1996) · Nature · doi:10.1038/382551a0 · Cited by 663 · cited 1×
“This is in contrast to MEFs from KU80 / , ATM / , or BRCA2 mutant mice, which are deficient in certain DNA damage responses (Barlow et al., 1996; Nussenzweig et al., 1996; Xu and Baltimore, 1996).”
ResultSenescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells.
Chen, Q., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4130 · Cited by 641 · cited 1×
“…been demonstrated that these growth-inhibitory genes can also be activated in cell culture due to a variety of environmental stresses that have been termed premature senescence, culture shock, stasis, and stress-induced senescence (Chen and Ames, 1994; Serrano et al., 1997; Ramirez et al., 2001).”
BackgroundLi, B., Oestreich, S., & de Lange, T. (2000) · Cell · doi:10.1016/s0092-8674(00)80858-2 · Cited by 583 · cited 1×
“…and form a complex providing a protective cap over the ends of the chromosomes that protects chromosome termini from degradation, recombination, and end-joining reactions (van Steensel et al., 1998; Kim et al., 1999; Li et al., 2000; Bailey et al., 2001; Baumann and Cech, 2001; de Lange, 2002).”
BackgroundHeterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
Elenbaas, B., & Weinberg, R. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5133 · Cited by 558 · cited 1×
“The paracrine effects of p21 induction mimic the tumor-promoting activities that are present not only in normal senescent fibroblasts (Krtolica et al., 2001) but also in tumor-associated stromal fibroblasts (Elenbaas and Weinberg, 2001).”
BackgroundPhinney, D. G., Kopen, G. C., Isaacson, R. L., & Prockop, D. J. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990315)72:4<483::aid-jcb4>3.0.co;2-i · Cited by 551
Blackburn, E. H. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.000553 · Cited by 542
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539 · cited 1×
“Instead, most observations suggest that telomerase inhibition by small molecules (Herbert et al., 1999) or by dominant-negative Oncogene mutants (Hahn et al., 1999) produces cell death rather than senescence in tumor cell lines.”
BackgroundSelf-citationT-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang
M.Stansel, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5532 · Cited by 534
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527
TIN2, a new regulator of telomere length in human cells
Kim, S.-H., Kaminker, P., & Campisi, J. (1999) · Nature Genetics · doi:10.1038/70508 · Cited by 525
Robles, S. J., & Adami, G. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201862 · Cited by 498 · cited 1×
“…response to oncogenic Ras or Raf, oligonucleotides, inadequate culture conditions, or the limited proliferation of mouse embryonic fibroblasts with very long telomeres operates just as effectively in human cells expressing telomerase (Serrano et al., 1997; Robles and Adami, 1998; Zhu et al., 1998).”
BackgroundDifferent telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 474
In vivo loss of telomeric repeats with age in humans
Lindsey, J., McGill, N. I., Lindsey, L. A., Green, D. K., & Cooke, H. J. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90032-7 · Cited by 463
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444
Self-citationRoninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443 · cited 3×
“Induction of tumor cell senescence by chemotherapy (as detected by SA-b-gal staining) also occurs in vivo (Roninson, 2002a) as demonstrated in nude mouse xenografts of human tumor cell lines (Roninson et al., 2001; Elmore et al., 2002), in carcinogen-induced rat mammary tumors (Christov et al.,…”
BackgroundSelf-citationThe telomerase reverse transcriptase: components and regulation
Nugent, C. I., & Lundblad, V. (1998) · Genes & Development · doi:10.1101/gad.12.8.1073 · Cited by 438
Chang, B.-D., Watanabe, K., Broude, E. V., Fang, J., Poole, J. C., Kalinichenko, T. V., & Roninson, I. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4291 · Cited by 432 · cited 6×
“In fact, p21 induction alone was shown (in HT1080 fibrosarcoma) to be sufficient to shut off the same genes (Chang et al., 2000b), by inhibiting transcription through negative regulatory elements in the promoters of such genes (Zhu et al., 2002).”
BackgroundInfluentialSelf-citationTelomerase contributes to tumorigenesis by a telomere length-independent mechanism
Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182407599 · Cited by 431 · cited 1×
“Recently it has been shown that there is an antiapoptotic function of telomerase, which may be independent of its effect on telomeres (Stewart et al., 2002).”
BackgroundDual roles of ATM in the cellular response to radiation and in cell growth control.
Xu, Y., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.19.2401 · Cited by 403
Wright, W. E., & Shay, J. W. (2000) · Nature Medicine · doi:10.1038/78592 · Cited by 398
Self-citationTelomerase activity in human cancer
Shay, J. W., & Wright, W. E. (1996) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199601000-00012 · Cited by 398 · cited 1×
“The maintenance of telomere stability is almost universally required for the long-term proliferation of tumors (Shay, 1995; Shay and Wright, 1996a, b; Holt and Shay, 1999).”
BackgroundSelf-citationChang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 386 · cited 12×
“This effect of retinoids has been observed in malignant and premalignant human and rat breast carcinoma cells, in vitro and in vivo (Chang et al., 1999a; Christov et al., 2003), and in a neuroblastoma cell line (Wainwright et al., 2001).”
BackgroundInfluentialSelf-citationThe two-stage mechanism controlling cellular senescence and immortalization
Wright, W. E., & Shay, J. W. (1992) · Experimental Gerontology · doi:10.1016/0531-5565(92)90069-c · Cited by 383
Self-citationShort Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367
Historical claims and current interpretations of replicative aging
Wright, W. E., & Shay, J. W. (2002) · Nature Biotechnology · doi:10.1038/nbt0702-682 · Cited by 357
Self-citationTelomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A. (2000) · Nature Genetics · doi:10.1038/79089 · Cited by 347
DeFilippis, R. A., Goodwin, E. C., Wu, L., & DiMaio, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1551-1563.2003 · Cited by 334 · cited 1×
“The senescent phenotype is also induced by a small interfering RNA molecule targeting the bicistronic E6 and E7 mRNA (Hall and Alexander, 2003), or by the inhibition of E6 or E7 individually (DeFilippis et al., 2003).”
BackgroundPositive correlation between mammalian life span and cellular resistance to stress
Kapahi, P., Boulton, M. E., & Kirkwood, T. B. L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00323-2 · Cited by 325
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312 · cited 10×
“Since p53- and p21-null cells are still able to undergo drug-induced senescence (albeit at a diminished rate) (Chang et al., 1999b), inhibition of cell cycle progression genes does not appear to be an absolute requirement for this arrest (Chang et al., 2002).”
BackgroundInfluentialSelf-citationTelomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation
Wong, K.-K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., et al. (2000) · Nature Genetics · doi:10.1038/79232 · Cited by 309
Cellular senescence as a tumor-protection mechanism: the essential role of counting
Wright, W. E., & Shay, J. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00163-5 · Cited by 306 · cited 1×
“While mice and humans get about the same lifetime frequency of cancer (about 30%), there is also compelling evidence that rodent cells do not use the same mechanism as human cells to regulate the maximal number of cell divisions (Wright and Shay, 2001, 2002; Shay and Wright, 2001).”
BackgroundSelf-citationTelomerase and the maintenance of chromosome ends
Bryan, T. M., & Cech, T. R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80043-x · Cited by 301 · cited 3×
“…in the vast majority of human cancers, rare human cell lines and tumors that lack telomerase activity have been reported that are able to maintain or elongate their telomeres by alternative mechanisms, which have been termed ALT (Bryan et al., 1995; Bryan et al., 1997; Bryan and Cech, 1999).”
BackgroundInfluentialWild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
Sugrue, M. M., Shin, D. Y., Lee, S. W., & Aaronson, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9648 · Cited by 292 · cited 1×
“…ability of tumor cells to recover once the expression of a growth-inhibitory gene has been turned off has been investigated for p53, p21, and p16 tumor suppressors, expressed in tumor cells from regulated promoters (Sugrue et al., 1997; Chang et al., 2000a; Fang et al., 1999; Day and Enders 2000).”
BackgroundChen, Q., Ijpma, A., & Greider, C. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1819-1827.2001 · Cited by 279
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271 · cited 3×
“This response is not associated with telomere shortening and is not prevented by the overexpression of telomerase (Elmore et al., 2002), indicating that it should be classified as STASIS rather than replicative senescence.”
BackgroundFrom cells to organisms: can we learn about aging from cells in culture?
Campisi, J. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00230-8 · Cited by 267
Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin
Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., & Wyche, J. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112401200 · Cited by 262 · cited 1×
“…morphological changes and SA-b-gal expression in cell lines derived from a variety of human solid tumors (Wang et al., 1998; Chang et al., 1999a; Michishita et al., 1999; Park et al., 2000; Suzuki et al., 2001; Elmore et al., 2002; Han et al., 2002; Haq et al., 2002; te Poele et al., 2002).”
BackgroundRole of telomerase in cellular proliferation and cancer
Holt, S. E., & Shay, J. W. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<10::aid-jcp2>3.0.co;2-d · Cited by 259 · cited 1×
“The maintenance of telomere stability is almost universally required for the long-term proliferation of tumors (Shay, 1995; Shay and Wright, 1996a, b; Holt and Shay, 1999).”
BackgroundSelf-citationStrand-Specific Postreplicative Processing of Mammalian Telomeres
Bailey, S. M., Cornforth, M. N., Kurimasa, A., Chen, D. J., & Goodwin, E. H. (2001) · Science · doi:10.1126/science.1062560 · Cited by 258 · cited 1×
“…and form a complex providing a protective cap over the ends of the chromosomes that protects chromosome termini from degradation, recombination, and end-joining reactions (van Steensel et al., 1998; Kim et al., 1999; Li et al., 2000; Bailey et al., 2001; Baumann and Cech, 2001; de Lange, 2002).”
BackgroundVariability at the Telomeres of the Human X/Y Pseudoautosomal Region
Cooke, H. J., & Smith, B. A. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.026 · Cited by 233 · cited 1×
“…repetitive TTAGGG tracts followed by a single-strand overhang on the 30 G-rich strand that ends in a lariat-like structure called a t-loop (Blackburn and Gall, 1978; Cooke and Smith, 1986; Moyzis et al., 1988; Chong et al., 1995; Broccoli et al., 1997; Griffith et al., 1999; Stansel et al., 2001).”
BackgroundLack of Replicative Senescence in Cultured Rat Oligodendrocyte Precursor Cells
Tang, D. G., Tokumoto, Y. M., Apperly, J. A., Lloyd, A. C., & Raff, M. C. (2001) · Science · doi:10.1126/science.1056780 · Cited by 228 · cited 3×
“The ability to obtain immortalized MEFs of the rodents in culture conditions (Loo et al., 1987; Mathon et al., 2001; Tang et al., 2001) probably results from combining an environment that minimizes ‘stress’ while including enough of the right hormones and other factors to balance the stresses that…”
BackgroundShort Telomeres Result in Organismal Hypersensitivity to Ionizing Radiation in Mammals
Goytisolo, F. A., Samper, E., Martín-Caballero, J., Finnon, P., Herrera, E., Flores, J. M., Bouffler, S. D., & Blasco, M. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1625 · Cited by 226 · cited 3×
“These studies show that in late generation Terc / mice irradiated with gamma-irradiation showed an enhanced mortality (Goytisolo et al., 2000; Wong et al., 2000).”
BackgroundInfluentialThe DNA structures at the ends of eukaryotic chromosomes
Wellinger, R. J., & Sen, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00067-1 · Cited by 223
Extended Culture of Mouse Embryo Cells Without Senescence: Inhibition by Serum
Loo, D. T., Fuquay, J. I., Rawson, C. L., & Barnes, D. W. (1987) · Science · doi:10.1126/science.3494308 · Cited by 219 · cited 1×
“The ability to obtain immortalized MEFs of the rodents in culture conditions (Loo et al., 1987; Mathon et al., 2001; Tang et al., 2001) probably results from combining an environment that minimizes ‘stress’ while including enough of the right hormones and other factors to balance the stresses that…”
BackgroundPapillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21CIP-dependent pathways
Wells, S. I. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5762 · Cited by 207
Fang, L., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202615 · Cited by 207 · cited 1×
“…ability of tumor cells to recover once the expression of a growth-inhibitory gene has been turned off has been investigated for p53, p21, and p16 tumor suppressors, expressed in tumor cells from regulated promoters (Sugrue et al., 1997; Chang et al., 2000a; Fang et al., 1999; Day and Enders 2000).”
BackgroundCaspase inhibition switches doxorubicin-induced apoptosis to senescence
Rebbaa, A., Zheng, X., Chou, P. M., & Mirkin, B. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206366 · Cited by 201 · cited 1×
“…illustrated by the studies where inhibition of apoptosis by various means was shown to increase mitotic catastrophe ending in micronucleation (Lock and Stribinskiene, 1996), senescence (Schmitt et al., 2002; Rebbaa et al., 2003), or both mitotic catastrophe and senescence (Ruth and Roninson, 2000).”
BackgroundRNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells
Hall, A. H. S., & Alexander, K. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.6066-6069.2003 · Cited by 196 · cited 1×
“The senescent phenotype is also induced by a small interfering RNA molecule targeting the bicistronic E6 and E7 mRNA (Hall and Alexander, 2003), or by the inhibition of E6 or E7 individually (DeFilippis et al., 2003).”
BackgroundLack of Replicative Senescence in Normal Rodent Glia
Mathon, N. F., Malcolm, D. S., Harrisingh, M. C., Cheng, L., & Lloyd, A. C. (2001) · Science · doi:10.1126/science.1056782 · Cited by 185 · cited 3×
“The ability to obtain immortalized MEFs of the rodents in culture conditions (Loo et al., 1987; Mathon et al., 2001; Tang et al., 2001) probably results from combining an environment that minimizes ‘stress’ while including enough of the right hormones and other factors to balance the stresses that…”
BackgroundRapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176 · cited 2×
“Expression of bovine papillomavirus protein E2, a negative regulator of both E6 and E7, rapidly induces stable growth arrest and the senescent phenotype in HeLa cells and human cervical carcinoma cell lines (Goodwin et al., 2000; Wells et al., 2000).”
Backgroundp16INK4a can initiate an autonomous senescence program
Dai, C. Y., & Enders, G. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203438 · Cited by 169
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168 · cited 6×
“In fact, p21 induction alone was shown (in HT1080 fibrosarcoma) to be sufficient to shut off the same genes (Chang et al., 2000b), by inhibiting transcription through negative regulatory elements in the promoters of such genes (Zhu et al., 2002).”
BackgroundInfluentialSelf-citationRecombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase
Cohen, H., & Sinclair, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061579598 · Cited by 156
Eriko, M., Nakabayashi, K., Suzuki, T., Kaul, S. C., Ogino, H., Fujii, M., Mitsui, Y., & Ayusawa, D. (1999) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022549 · Cited by 152
Immortalisation and transformation revisited
Drayton, S., & Peters, G. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00271-4 · Cited by 148 · cited 3×
“Also, as in the case of replicative senescence, these cells remain metabolically and synthetically active and show characteristic changes in morphology (Dimri et al., 1995; Serrano et al., 1997; Drayton and Peters, 2002).”
BackgroundBertram, M. J., Bérubé, N. G., Hang-Swanson, X., Ran, Q., Leung, J. K., Bryce, S., Spurgers, K., Bick, R. J., Baldini, A., Ning, Y., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1479 · Cited by 143
The reactivation of telomerase activity in cancer progression
Shay, J. W., & Wright, W. E. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)30018-8 · Cited by 142 · cited 1×
“The maintenance of telomere stability is almost universally required for the long-term proliferation of tumors (Shay, 1995; Shay and Wright, 1996a, b; Holt and Shay, 1999).”
BackgroundSelf-citationStress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53
Komarova, E. A., Diatchenko, L. B., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., & Gudkov, A. V. (1998) · Oncogene · doi:10.1038/sj.onc.1202303 · Cited by 140 · cited 1×
“Such activity was in fact demonstrated in conditioned media and coculture assays with drugtreated cells, where the induction of secreted tumorsuppressing proteins was reported to be mediated by p53 (Komarova et al., 1998).”
BackgroundTelomerase and chromosome end maintenance
Lingner, J., & Cech, T. R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80145-7 · Cited by 131 · cited 1×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundTransforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells
Katakura, Y., Nakata, E., Miura, T., & Shirahata, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0129 · Cited by 129 · cited 2×
“Coinduction of multiple growth inhibitors in senescent cells was also observed in BrdU-induced senescence of HeLa cells (Suzuki et al., 2001) and in retinoid-induced senescence (Dokmanovic et al., 2002) Genes induced in senescent HCT116 cells encode intracellular growth-inhibiting proteins p21, BTG1, BTG2, EPLIN (epit…”
BackgroundDefects in mismatch repair promote telomerase-independent proliferation
Rizki, A., & Lundblad, V. (2001) · Nature · doi:10.1038/35079641 · Cited by 126 · cited 1×
“ALT can also be enhanced by eliminating the mismatch repair (inhibits homologous recombination) pathway in yeast (Rizki and Lundblad, 2001).”
BackgroundAging and cancer: are telomeres and telomerase the connection?
Shay, J. W. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)93872-9 · Cited by 116
Self-citationTelomere dysfunction alters the chemotherapeutic profile of transformed cells
Lee, K.-H., Rudolph, K. L., Ju, Y.-J., Greenberg, R. A., Cannizzaro, L., Chin, L., Weiler, S. R., & DePinho, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629198 · Cited by 111 · cited 1×
“Functional p53 is believed to be required for the enhanced response of late-generation Terc / cell to DNA-damaging reagents (Lee et al., 2001).”
BackgroundWainwright, L. J., Lasorella, A., & Iavarone, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161288698 · Cited by 106 · cited 2×
“This effect of retinoids has been observed in malignant and premalignant human and rat breast carcinoma cells, in vitro and in vivo (Chang et al., 1999a; Christov et al., 2003), and in a neuroblastoma cell line (Wainwright et al., 2001).”
BackgroundMultiple pathways for the regulation of telomerase activity
Holt, S. E., Wright, W. E., & Shay, J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00066-x · Cited by 103
Self-citationInduction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells
Suzuki, T., Minagawa, S., Michishita, E., Ogino, H., Fujii, M., Mitsui, Y., & Ayusawa, D. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00223-0 · Cited by 99
Retinoic Acid Inhibition of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells
Zhu, W.-Y., Jones, C. S., Kiss, A., Matsukuma, K. E., Amin, S., & Luca, L. M. D. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3589 · Cited by 97 · cited 1×
“Furthermore, retinoid treatment decreases rather than increases p21 expression in MCF-7 cells (Zhu et al., 1997), providing a likely reason for noninduction of disease-associated genes.”
BackgroundSodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells
Terao, Y., Nishida, J.-I., Horiuchi, S., Rong, F., Ueoka, Y., Matsuda, T., Kato, H., Furugen, Y., Yoshida, K., Kato, K., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1448 · Cited by 89
Desmoid tumors in adults: The role of radiotherapy in their management
Batalni, J. P., Belloir, C., Mazabraud, A., Pilleron, J. P., Cartigny, A., Jaulerry, C., & Ghossein, N. Ā. (1988) · The American Journal of Surgery · doi:10.1016/s0002-9610(88)80037-0 · Cited by 86
Shay, J. W., & Wright, W. E. (2001) · Science · doi:10.1126/science.1058546 · Cited by 83 · cited 4×
“When some telomeres are short, cells undergo a growth arrest called replicative senescence (Hayflick and Moorhead, 1961; Harley et al., 1990; Shay and Wright, 2001).”
BackgroundInfluentialSelf-citationTumor senescence as a determinant of drug response in vivo
Roninson, I. B. (2002) · Drug Resistance Updates · doi:10.1016/s1368764602001103 · Cited by 83 · cited 3×
“Induction of tumor cell senescence by chemotherapy (as detected by SA-b-gal staining) also occurs in vivo (Roninson, 2002a) as demonstrated in nude mouse xenografts of human tumor cell lines (Roninson et al., 2001; Elmore et al., 2002), in carcinogen-induced rat mammary tumors (Christov et al.,…”
BackgroundSelf-citationSprenger, C. C. T., Vail, M. E., Evans, K., Simurdak, J., & Plymate, S. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205021 · Cited by 80 · cited 1×
“…by a putative tumor-suppressor gene INI1 (Reincke et al., 2003), by IGFBP-rP1, a member of the insulin-like growth factor binding protein family (Sprenger et al., 2002), and by constitutively active mutants of two genes stimulating the MAPK pathway, including RAF-1 and MAPK kinase MKK6 (Ravi et…”
BackgroundGasser, S. M. (2000) · Science · doi:10.1126/science.288.5470.1377 · Cited by 78 · cited 1×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundRaf-1-induced cell cycle arrest in LNCaP human prostate cancer cells
Ravi, R. K., McMahon, M., Yangang, Z., Williams, J. R., Dillehay, L. E., Nelkin, B. D., & Mabry, M. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990315)72:4<458::aid-jcb2>3.0.co;2-c · Cited by 76 · cited 2×
“…gene INI1 (Reincke et al., 2003), by IGFBP-rP1, a member of the insulin-like growth factor binding protein family (Sprenger et al., 2002), and by constitutively active mutants of two genes stimulating the MAPK pathway, including RAF-1 and MAPK kinase MKK6 (Ravi et al., 1999; Haq et al., 2002).”
BackgroundDokmanovic, M., Chang, B.-D., Fang, J., & Roninson, I. B. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.35 · Cited by 70
Self-citationBcl-2 activates a programme of premature senescence in human carcinoma cells
CRESCENZI, E., PALUMBO, G., & BRADY, H. J. M. (2003) · Biochemical Journal · doi:10.1042/bj20030868 · Cited by 69
Telomerase and telomere-binding proteins: Controlling the endgame
Shore, D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01082-7 · Cited by 67
Bcl-2 promotes premature senescence induced by oncogenic Ras
Tombor, B., Rundell, K., & Oltvai, Z. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00402-9 · Cited by 61 · cited 1×
“The prosenescence role of Bcl2 was also indicated by the report that expression of this protein accelerates Rasinduced senescence in human fibroblasts (Tombor et al., 2003).”
BackgroundDubrana, K., Perrod, S., & Gasser, S. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00210-6 · Cited by 60 · cited 1×
“…or depleted, cells undergo chromosome end associations and fusions leading to growth arrest or death (Makarov et al., 1997; Shore, 1997; Wellinger and Sen, 1997; Lingner and Cech, 1998; Blackburn, 2000; Gasser, 2000; Dubrana et al., 2001; Karlseder et al., 2002; Smogorzewska and de Lange, 2002).”
BackgroundGenetics of cellular senescence
Tominaga, K., Olgun, A., Smith, J. R., & Pereira‐Smith, O. M. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00030-1 · Cited by 57 · cited 1×
“As reviewed by Tominaga et al. (2002), these studies revealed four senescence-determining complementation groups.”
BackgroundGorbunova, V., Seluanov, A., & Pereira-Smith, O. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212944200 · Cited by 56 · cited 1×
“The senescence-promoting and senescence-suppressing factors in tumor cells exist in a dynamic equilibrium, which is perhaps best illustrated by the report that overexpression of hTERT not only inhibits but – at very high levels – also promotes senescence (Gorbunova et al., 2003).”
BackgroundKIM, J. H., KIM, J. H., Lee, G. E., KIM, S. W., & CHUNG, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 55
Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell
Park, J., Jeong, J., Han, J., Kim, D.-I., Gao, Y.-H., Park, S.-C., Rodgers, G. P., & Kim, I.-H. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050013 · Cited by 54
Reincke, B. S., Rosson, G. B., Oswald, B. W., & Wright, C. F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10201 · Cited by 53 · cited 2×
“Tumor cell senescence was also induced by a putative tumor-suppressor gene INI1 (Reincke et al., 2003), by IGFBP-rP1, a member of the insulin-like growth factor binding protein family (Sprenger et al., 2002), and by constitutively active mutants of two genes stimulating the MAPK pathway, including…”
BackgroundCox, J. D., & Kline, R. W. (1983) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(83)90287-0 · Cited by 53
Herbert, B., Wright, A., Passons, C., Wright, W. E., Ali, I., Kopelovich, L., & Shay, J. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.39 · Cited by 53 · cited 1×
“In addition, very low concentrations of 9 and 13-cis retinoic acid have been shown to prevent the spontaneous immortalization of a breast epithelial cells derived from a Li–Fraumeni patient (methylated for p16 and heterozygous for p53) (Herbert et al., 2001).”
BackgroundSelf-citationIntravenous morphine for emergency treatment of cancer pain
Kumar, S., Rajagopal, M. R., & Naseema, A. M. (2000) · Palliative Medicine · doi:10.1191/026921600670697351 · Cited by 37
Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours
Christov, K. T., Shilkaitis, A. L., Kim, E. S., Steele, V. E., & Lubet, R. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00497-5 · Cited by 36
Smithsonian closure plan under fire
Chen, J. (2001) · Nature · doi:10.1038/35074250 · Cited by 11
&NA; (2003) · Drugs · doi:10.2165/00003495-200363240-00001 · Cited by 10
Telomerase activity in human germline and embryonic tissues and cells
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., & Shay, J. W. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)18:2<173::aid-dvg10>3.0.co;2-3
Self-citation
Research works printed but not linked: 2
- Roninson IB and Dokmanovic M . (2002). J. Cell Biochem., 1–12. · DOI · Paper page
- Wright WE and Shay JW . (1996). In Modern Cell Biology Series, Holbrook NJ, Martin GR (eds) Wiley–Liss Inc.: New York, pp 153–167.
Cited by
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
“In addition, some tumor cells retain the ability to senesce (Shay and Roninson, 2004), and do so in vivo in response to chemotherapy (Schmitt et al.”
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
“In this case, they would be likely to remai n dormant 151 permanently, as replicative senescence is generally believed to be irrever s bl [16].”
Metadata
- Authors
- Shay, J. W., & Roninson, I. B.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Roninson, Igor B
- Venue
- Oncogene
- Published
- 2004-04-12
- Volume
- 23
- Issue
- 16
- Pages
- 2919-2933
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2062107951
- Semantic Scholar
- bbc4d783cfd91b0ed59075622e40a9d18c5e0879
- Cited by
- 502
- References
- 150
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 14 · 2023: 6 · 2022: 10 · 2021: 14 · 2020: 15 · 2019: 12 · 2018: 16 · 2017: 20 · 2016: 29 · 2015: 36 · 2014: 31 · 2013: 27 · 2012: 28
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG017921, R01AG007992)
- National Cancer Institute (R01CA089636, P50CA070907, R01CA062099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, carcinogenesis, cancer therapy, replicative senescence, telomere shortening, Stasi, DNA double-strand breaks, cell cycle checkpoints, DNA repair, senescence-associated secretory phenotype, tumor suppressor, oncogenes, DNA damage signaling, apoptosis
- MeSH terms
- Animals, DNA Repair, Histones, Humans, Neoplasms, Retinoids, Signal Transduction, Gene Expression Regulation, Neoplastic, Telomere, Cellular Senescence, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.